FDA Inspection 779103 — AGC Biologics, Inc.

AGC Biologics, Inc. — FEI 3000209996

The FDA completed an inspection of AGC Biologics, Inc. on Apr 18, 2012 in Bothell, WA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Apr 18, 2012
Fiscal Year
2012
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Bothell, WA (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.